STOCK TITAN

RenovoRx grants Richard Stark 128,824 stock options

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

RenovoRx, Inc. director Richard Stark received a grant of 128,824 stock options to buy common stock on November 18, 2026, with an exercise price of $1.12 per share. The options vest in 36 equal monthly installments on the 18th of each month beginning December 18, 2026, subject to his continued service, and vest in full upon a change in control.

Insider Stark Richard
Role Director
Type Security Shares Price Value
Grant/Award Stock Option (right to buy) F1 128,824 $0.00 $0.00
Holdings After Transaction: Stock Option (right to buy) — 128,824 options (Direct)
Holdings Before and After: Stock Option (right to buy), 0 to 128,824 options (Direct)
Footnotes (1)
  1. F1. The option vests and becomes exercisable in 36 equal monthly installments on the 18th day of each month beginning December 18, 2026, subject to the Reporting Person's continued service, and vests in full upon a change in control of the Issuer.
Stock options awarded 128,824 options Granted to Richard Stark on November 18, 2026.
Options following award 128,824 options Reported position following the award to Richard Stark.
Exercise price $1.12 per share Price to exercise the options.
Vesting schedule 36 equal monthly installments Installments begin December 18, 2026, subject to continued service; the options vest in full upon a change in control.
Expiration date November 17, 2036 Expiration date of the options.
exercisable technical
"the options vest and become exercisable in 36 equal monthly installments"
vesting technical
"the options vest in full upon a change in control"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
change in control technical
"vests in full upon a change in control of the Issuer"
A "change in control" occurs when the ownership or management of a company shifts significantly, such as through a merger, acquisition, or sale of a large part of its assets. This change can impact how the company is run and may influence its future direction. For investors, it matters because it can affect the company's stability, strategy, and value, often signaling potential changes in investment risk or opportunity.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many options did RenovoRx (RNXT) director Richard Stark receive?

Richard Stark received 128,824 options to buy common stock at an exercise price of $1.12 per share.

When do Richard Stark's RNXT options expire?

The options expire on November 17, 2036.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Stark Richard

(Last)(First)(Middle)
C/O RENOVORX, INC.
2570 W EL CAMINO REAL, SUITE 640

(Street)
MOUNTAIN VIEW CALIFORNIA 94040

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
RenovoRx, Inc. [ RNXT ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
11/18/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (right to buy)$1.1211/18/2026A128,824 (1)11/17/2036Common Stock128,824$0128,824D
Explanation of Responses:
1. The option vests and becomes exercisable in 36 equal monthly installments on the 18th day of each month beginning December 18, 2026, subject to the Reporting Person's continued service, and vests in full upon a change in control of the Issuer.
/s/ Richard Stark11/20/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading